Dr. Sandra Amaral, attending physician in CHOP’s Division of Nephrology and the Kidney Transplant and Dialysis Program, led a study recently published in JAMA that found an association between dialysis facility ownership and access to the waiting list and transplant in pediatric patients with end-stage kidney disease in the United States. The findings were covered in this Kaiser Health News article.  

A new study by a multi-institutional group of pediatric cancer researchers, including those at CHOP, has characterized the genomic landscape for acute lymphoblastic leukemia.

First-of-its-kind study identifies differences between sexes as well as ethnic background.

Variants of the FBXL4 gene cause a severe form of the disorder with many complications and no approved treatment options.

New study shows how nicotimamide riboside, part of the vitamin B3 family, could mitigate myopathy caused by a genetic variant.

Nearly 1 in 3 adolescents reported elevated symptoms of depression in the first four weeks after concussion.

The study found that the approach utilized in the study significantly reduced emergency room visits and hospitalizations related to the disorder.

CHOP researchers have discovered a new part of the regulatory cascade responsible for silencing fetal hemoglobin in adult cells.

Aligned with CHOP and AHA’s shared mission to improve cardiac care, grant supports research aiming to discover new hormones secreted from the heart.

CHOP neurosurgeons collaborated with researchers from the University of Pennsylvania School of Medicine to confirm the presence of these neurons from birth through age 92.